Two Sigma Investments
XGN icon

Two Sigma Investments’s Exagen XGN Stock Holding History

Two Sigma Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473K Sell
157,821
-210,429
-57% -$814K ﹤0.01% 3772
2025
Q4 		$2.24M Buy
368,250
+130,271
+55% +$1.19M ﹤0.01% 2352
2025
Q3 		$2.62M Buy
237,979
+174,979
+278% +$1.55M ﹤0.01% 1951
2025
Q2 		$440K Buy
+63,000
New +$383K ﹤0.01% 2643

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Two Sigma Investments's XGN Position: Q1 2026 in Review

Two Sigma Investments reduced its Exagen (XGN) stake by 57% in Q1 2026, selling an estimated $814K and leaving 157,821 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

Two Sigma Investments first reported a position in XGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.62M in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Two Sigma Investments held 157,821 shares of Exagen worth $473K as of Q1 2026.
  • Two Sigma Investments sold 210,429 Exagen shares in Q1 2026, an estimated $814K.
  • Exagen made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3772 holding.
  • Two Sigma Investments first reported a position in Exagen in Q2 2025 and has held it in 4 quarters since.
  • Two Sigma Investments's Exagen position peaked at $2.62M in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.